Direct detection of Influenza A, Influenza B &RSV from human nasal and throat swabs.
Coming soon
Pneumocystis
Qualitative detection of Pneumocystis jirovecii, one of the most dangerous opportunistic respiratory pathogens for immunocompromised patients.
Coming soon
Bordetella
Accurate and reliable discrimination of Bordetella pertussis, B. parapertussis and B. holmesii from human nasopharyngeal swabs.
Coming soon
Chronical Lung Disease Panel
The Chronical Lung Disease Panel detects up to 132 different species associated with long term lung diseases (e.g. Cystic Fibrosis, Chronic Obstructive Plumonary Disease (COPD) etc.), including bacterial, viral, fungal and antobiotic resistance markers.
Direct detection and discrimination of Norovirus, Rotavirus and C. Diff tcdA- and tcdB-gene to aid in the diagnosis of hospital-acquired gastroenteritis.
Coming soon
MRSA
Direct detection and discrimination of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA) or methicillin-resistant coagulase-negative Staphylococci from human nasal swabs.
Coming soon
Clostridium difficile
Direct qualitative detection of Clostridium difficile toxin A (tcd A), toxin B (tcd B) and binary toxin from human stool samples.
Coming soon
Gastrointestinale infeksjoner
Norovirus
Detection and discrimination of Norovirus genogroups I and II from stool samples.
Coming soon
Urineveisinfeksjoner
UTI Panel
Detect up to 21 bacterial pathogens and eight antibiotic resistance markers from the same patient urine sample.
